Prevalence, molecular characteristics and antimicrobial susceptibility patterns of MRSA in hospitalized and nonhospitalized patients in Barbados
- PMID: 32257222
- PMCID: PMC7110409
- DOI: 10.1016/j.nmni.2020.100659
Prevalence, molecular characteristics and antimicrobial susceptibility patterns of MRSA in hospitalized and nonhospitalized patients in Barbados
Abstract
The epidemiology and clonality of methicillin-resistant Staphylococcus aureus (MRSA) has not been investigated, as not much research or surveillance has been undertaken to identify and characterize the circulating MRSA strains in Barbados. Prevalence rates, molecular characteristics and antimicrobial susceptibility pattern of MRSA infections in hospitalized and nonhospitalized patients were investigated. A total of 293 isolates were included in the study, with 100 from the hospital and 193 from the public health laboratory. Isolates were collected over a period of 1 (2015-2016) and 3 years (2013-2016) respectively. MRSA was identified using standard microbiologic techniques and was further analysed by multiplex PCR for the presence of the spa, mec gene complex typing and PVL genes (lukS-PV and lukF-PV). A prevalence rate of 19.7% was calculated for those hospitalized. All hospital isolates were sensitive to vancomycin, rifampin, linezolid and cotrimoxazole (trimethoprim/sulfamethoxazole), whilst 82% were sensitive to clindamycin. The PVL gene was detected in 76% of hospital isolates. In the community isolates, resistance was observed in erythromycin (100%), ciprofloxacin (97.4%), clindamycin (13%) and cotrimoxazole (5.7%). There was no resistance to vancomycin. The PVL gene was detected in 97.9% of the isolates, the mecA gene in only 2.1% and the mecC gene in 0%. Most MRSA isolates were community acquired in both settings, and the antimicrobial susceptibility profile was similar, suggesting transmission of community-associated MRSA into the hospital environment. Further harmonization of antimicrobial policy for the treatment of MRSA (and by extension other pathogens) should be implemented to quell ongoing transmission. We found that 93.4% of MRSA in Barbados treated in the primary healthcare system were sensitive to cotrimoxazole. By typing MRSA isolates and drawing interferences on transmission on the basis of genetic relatedness, transmission pathways may be tracked. Further studies must be performed for this high level of comprehensiveness so that with the surveillance of MRSA, effective strategies may be developed to prevent or limit transmission.
Keywords: Antimicrobial resistance; CA-MRSA; HA-MRSA; MRSA; antimicrobial susceptibility; methicillin-resistant Staphylococcus aureus; molecular characteristics.
© 2020 The Authors.
Figures
Similar articles
-
[Epidemiological and molecular characteristics of hospital-acquired methicillin-resistant Staphylococcus aureus strains isolated in Hacettepe University Adult Hospital in 2004-2005].Mikrobiyol Bul. 2010 Jul;44(3):343-55. Mikrobiyol Bul. 2010. PMID: 21063984 Turkish.
-
Molecular characterization and antibiotic resistance of clinical isolates of methicillin-resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman).APMIS. 2014 May;122(5):405-11. doi: 10.1111/apm.12158. Epub 2013 Sep 6. APMIS. 2014. PMID: 24033803
-
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.Pediatr Pulmonol. 2014 Mar;49(3):230-7. doi: 10.1002/ppul.22815. Epub 2013 Jun 14. Pediatr Pulmonol. 2014. PMID: 23765686
-
[Infectivity-resistotype-genotype clustering of methicillin-resistant Staphylococcus aureus strains in the Central Blacksea Region of Turkey].Mikrobiyol Bul. 2014 Jan;48(1):14-27. Mikrobiyol Bul. 2014. PMID: 24506712 Turkish.
-
Molecular and phenotypic characterization of methicillin-resistant Staphylococcus aureus isolates from a tertiary hospital in the Philippines.Trop Med Health. 2016 Mar 14;44:3. doi: 10.1186/s41182-016-0003-z. eCollection 2016. Trop Med Health. 2016. PMID: 27398062 Free PMC article.
Cited by
-
Progress in the Prevalence, Classification and Drug Resistance Mechanisms of Methicillin-Resistant Staphylococcus aureus.Infect Drug Resist. 2023 May 25;16:3271-3292. doi: 10.2147/IDR.S412308. eCollection 2023. Infect Drug Resist. 2023. PMID: 37255882 Free PMC article. Review.
-
Recent development and fighting strategies for lincosamide antibiotic resistance.Clin Microbiol Rev. 2024 Jun 13;37(2):e0016123. doi: 10.1128/cmr.00161-23. Epub 2024 Apr 18. Clin Microbiol Rev. 2024. PMID: 38634634 Free PMC article. Review.
-
Comparison of risk factors for Methicillin Resistant Staphylococcus aureus (MRSA) colonization in healthy newborns, born to mothers with and without MRSA colonization.Pak J Med Sci. 2024 Jan-Feb;40(1Part-I):84-88. doi: 10.12669/pjms.40.1.7703. Pak J Med Sci. 2024. PMID: 38196494 Free PMC article.
-
High prevalence of Panton-Valentine leukocidin positive, multidrug resistant, Methicillin-resistant Staphylococcus aureus strains circulating among clinical setups in Adamawa and Far North regions of Cameroon.PLoS One. 2022 Jul 8;17(7):e0265118. doi: 10.1371/journal.pone.0265118. eCollection 2022. PLoS One. 2022. PMID: 35802616 Free PMC article.
-
Occurrence of mecA and blaZ genes in methicillin-resistant Staphylococcus aureus associated with vaginitis among pregnant women in Ado-Ekiti, Nigeria.New Microbes New Infect. 2020 Oct 1;38:100772. doi: 10.1016/j.nmni.2020.100772. eCollection 2020 Nov. New Microbes New Infect. 2020. PMID: 33133613 Free PMC article.
References
-
- Jevons M.P. ‘Celbenin’-resistant staphylococci. Br Med J. 1961;1(5219):124–125.
-
- Ayliffe G.A. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1997;24(Suppl. 1):S74–S79. - PubMed
-
- World population review. Barbados population; 2019. http://worldpopulationreview.com/countries/barbados-population/ Available at:
LinkOut - more resources
Full Text Sources